Full Breakdown
Federal Court Blocks Trump Administration's Declaration on Gender-Affirming Care for Minors
3/24/2026, 9:04:07 PM
Overview of the Court Ruling
A federal district court in Oregon has ruled against a declaration from the U.S. Department of Health and Human Services (HHS) that sought to restrict gender-affirming care for transgender minors. Judge Mustafa Kasubhai granted a motion for summary judgment in favor of Michigan Attorney General Dana Nessel and a coalition of 21 states, including Oregon, California, and New York, blocking the declaration issued by HHS Secretary Robert F. Kennedy Jr. The ruling, delivered on March 19, 2026, asserts that the federal government cannot threaten healthcare providers with the loss of Medicare and Medicaid funding for offering gender-affirming treatments.
Background of the Declaration
The declaration, titled “Safety, Effectiveness, and Professional Standards of Care for Sex-Rejecting Procedures on Children and Adolescents,” claimed that gender-affirming procedures are neither safe nor effective for minors. It warned that hospitals could face exclusion from federal health programs if they provided such care. This declaration followed a broader initiative by the Trump administration to limit access to gender-affirming treatments, including puberty blockers and hormone therapy, which had already led some Wisconsin pediatric hospitals to pause these services.
Legal Arguments and Implications
The states challenging the declaration argued that it exceeded the Secretary's authority and violated the Administrative Procedure Act. They contended that Kennedy's attempt to impose a national standard on gender-affirming care undermined established medical practices recognized by major organizations, including the American Medical Association and the American Academy of Pediatrics. Legal experts noted that the ruling is significant as it reaffirms the rights of states to regulate medical practices without federal overreach.
Criticism of the Declaration
Critics of the Trump administration's declaration highlighted that it misrepresented the medical consensus surrounding gender-affirming care. Major medical organizations have consistently supported such treatments as safe and effective, emphasizing that decisions regarding care should be made between families and healthcare providers. The declaration's reliance on a report that raised concerns about the risks of hormone therapy was met with skepticism, as it did not reflect the realities of pediatric care.
Official Statements & Responses
In response to the ruling, Michigan Attorney General Dana Nessel expressed relief, stating, “The Court has affirmed that the federal government cannot unlawfully interfere with doctors providing essential healthcare.” Wisconsin Attorney General Josh Kaul added, “The federal government should be respecting people’s freedoms,” criticizing Kennedy's overreach. LGBTQ+ advocates celebrated the decision, asserting that it protects the rights of transgender youth to access necessary healthcare.
What's Next
The Trump administration is expected to appeal the court's decision, which could prolong the legal battle over gender-affirming care. Meanwhile, the ruling provides temporary relief to healthcare providers and families of transgender minors, ensuring that access to these essential services remains intact for the time being.
Conflicting Reports & Gaps
While the ruling has been celebrated by advocates for transgender rights, some reports indicate that the declaration had already caused significant disruptions in care, with over 40 hospitals pausing or ceasing gender-affirming treatments. The extent of the impact on individual providers and patients remains unclear, as the administration argues that the declaration was non-binding and did not directly harm providers at the time of the ruling.
